448 results
8-K
EX-99.1
INVA
Innoviva, Inc.
31 Jul 24
Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
4:17pm
to shareholders; the status and timing of clinical studies, data analysis and communication of results; the potential benefits and mechanisms of action
8-K
EX-99.1
INVA
Innoviva, Inc.
13 May 24
Corporate Presentation May 2024
9:27am
returns to shareholders; the status and timing of clinical studies, data analysis and communication of r esu lts; the potential benefits and mechanisms … XERAVA use follows the key tenets of antibiotic stewardship which, among other benefits, helps reduce C. difficile infections 4 Simple administration
8-K
EX-99.1
INVA
Innoviva, Inc.
8 May 24
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
4:44pm
capital returns to shareholders; the status and timing of clinical studies, data analysis and communication of results; the potential benefits
8-K
EX-99.1
6igshtf5g3rq1ekklf
29 Feb 24
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
ygdptwj5zb ol58zj
1 Nov 23
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:30pm
8-K
EX-10.1
fa922
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
pb9jsmr0mp57ip8fvlgb
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
b08ncsodruk 20e431r9
2 Aug 23
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
geb75 9v3iv28mdo
24 May 23
Corporate Presentation May 2023
5:18pm
8-K
EX-99.1
z91vkwsdpwcdye
9 May 23
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent
5:21pm